Journal profile · Immunology
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
ISSN 1079-9907 · eISSN 1557-7465 · Mary Ann Liebert Inc. · UNITED STATES · Monthly · Founded 1995
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.9; hybrid open access; review about 2.2 months (community reports); community-reported acceptance: about 52.5%; 41 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH is published by Mary Ann Liebert Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are interferon and immune responses, Cytokine Signaling Pathways and Interactions and Immune Response and Inflammation, together about 38% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
Journal of Interferon & Cytokine Research (JICR) provides the latest groundbreaking research on all aspects of IFNs and cytokines. The Journal delivers current findings on emerging topics in this niche community, including the role of IFNs in the therapy of diseases such as multiple sclerosis, the understanding of the third class of IFNs, and the identification and function of IFN-inducible genes.
Source: LetPub
Research area (LetPub): Immunology
Editor-in-chief David L WoodlandPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named United States 39, Brazil 3, Japan 2, India 2, Australia 2 (53 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- interferon and immune responsesImmunology and Microbiology14.3%
- Cytokine Signaling Pathways and InteractionsMedicine12.5%
- Immune Response and InflammationImmunology and Microbiology11.2%
- Immune Cell Function and InteractionImmunology and Microbiology10.9%
- Immunotherapy and Immune ResponsesImmunology and Microbiology5.5%
- T-cell and B-cell ImmunologyImmunology and Microbiology5.3%
- Hepatitis C virus researchMedicine4.6%
- NF-κB Signaling PathwaysBiochemistry, Genetics and Molecular Biology3.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Cell Biology | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Cell Biology | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Cell Biology | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.9LetPub ·
- Impact factor (publisher)
- 1.9Publisher website ·
- 5-year impact factor (publisher)
- 2Publisher website ·
- CiteScore 2026-06
- 3.5LetPub ·
- SJR 2026-06
- 0.61LetPub ·
- SNIP 2026-06
- 0.45LetPub ·
- h-index
- 85LetPub ·
- h-index
- 123OpenAlex ·
- i10-index
- 1,943OpenAlex ·
- 2-year mean citedness
- 1.76OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 5.67%LetPub ·
Volume
- Articles per year
- 34LetPub ·
Articles by year OpenAlex count · 3,226 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 31 | 0 | 3 |
| 2025 | 41 | 6 | 45 |
| 2024 | 59 | 6 | 182 |
| 2023 | 68 | 19 | 504 |
| 2022 | 86 | 25 | 578 |
| 2021 | 65 | 8 | 602 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 2.2 monthsLetPub ·
- Average acceptance (community reports)
- 52.5%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websitePeer review
- Peer review
Journal name Model summary
Journal of Interferon & Cytokine Research
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Mary Ann Liebert Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1995
- ISSN
- 1079-9907
- Electronic ISSN
- 1557-7465
- Latest issue on the website
- Volume 46, Issue 9 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
What CAS zone is JOURNAL OF INTERFERON AND CYTOKINE RESEARCH in?
In the 2025 upgraded edition of the CAS Journal Ranking, JOURNAL OF INTERFERON AND CYTOKINE RESEARCH is in Zone 4 of Medicine, and in Zone 4 of the minor category Biochemistry & Molecular Biology / Cell Biology / Immunology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of JOURNAL OF INTERFERON AND CYTOKINE RESEARCH?
The latest impact factor listed by LetPub is 1.9; CiteScore 3.5, h-index 123.
How long does peer review take at JOURNAL OF INTERFERON AND CYTOKINE RESEARCH?
Authors report an average review time of about 2.2 months; the community-reported acceptance is “about 52.5%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of JOURNAL OF INTERFERON AND CYTOKINE RESEARCH based?
Of the 53 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are United States (39), Brazil (3) and Japan (2). Counted from the institutions listed on the board page; for reference only.
Which databases index JOURNAL OF INTERFERON AND CYTOKINE RESEARCH?
According to LetPub and DOAJ records, JOURNAL OF INTERFERON AND CYTOKINE RESEARCH is indexed in SCIE and Scopus.
Is JOURNAL OF INTERFERON AND CYTOKINE RESEARCH open access, and what is the APC?
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .